Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 10, 2021

SELL
$10.44 - $14.85 $1.36 Million - $1.93 Million
-130,000 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$6.53 - $14.42 $848,900 - $1.87 Million
130,000 New
130,000 $1.54 Million

Others Institutions Holding ALDX

About Aldeyra Therapeutics, Inc.


  • Ticker ALDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,323,100
  • Market Cap $280M
  • Description
  • Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...
More about ALDX
Track This Portfolio

Track Rovida Advisors Inc. Portfolio

Follow Rovida Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rovida Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rovida Advisors Inc. with notifications on news.